This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kura Oncology, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Kenneth K Liu: Innovator in Pharmaceutical Compounds
Introduction
Kenneth K Liu is a notable inventor based in Fremont, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of macrocyclic compounds. His work is crucial for advancing cancer treatment methodologies.
Latest Patents
Kenneth holds a patent for "Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same." This patent focuses on solid forms of Compound 1, which includes pharmaceutically acceptable forms, salts, and solvates. The patent also details pharmaceutical compositions and methods for treating cancer that depend on a farnesylated protein.
Career Highlights
Kenneth is currently employed at Kura Oncology, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in macrocyclic compounds has positioned him as a valuable asset in the fight against cancer.
Collaborations
Kenneth collaborates with various professionals in his field, including his coworker Yun Shan, to enhance the development of effective cancer treatments.
Conclusion
Kenneth K Liu's contributions to pharmaceutical innovations are noteworthy, particularly in the realm of cancer treatment. His patent and ongoing work at Kura Oncology, Inc. reflect his commitment to advancing medical science.